Procalcitonin Level and the High Risk of Mortality in 30 Days in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patient , Cases Series.
CompletedOBSERVATIONAL
Enrollment
582
Participants
Timeline
Start Date
January 1, 2020
Primary Completion Date
January 1, 2020
Study Completion Date
January 31, 2021
Conditions
the Relationship Between Procalcitonin and 30-day Mortality in COVID Patients
Trial Locations (1)
9999
younes Oujidi, Berkane
All Listed Sponsors
lead
Mohammed VI University Hospital
OTHER
NCT05008016 - Procalcitonin Level and the High Risk of Mortality in 30 Days in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patient , Cases Series. | Biotech Hunter | Biotech Hunter